Common use of Screening License Clause in Contracts

Screening License. Genentech agrees to grant and hereby grants (on behalf of itself and its Affiliates) Exelixis a worldwide, non-exclusive, royalty-bearing license, under the Yale Patents to the extent exclusively licensed to Genentech under Section 5.1 above, to screen Small Molecule Compounds against the Collaboration Targets. The foregoing license does not include the right to grant or authorize sublicenses, or to have any screening activities performed on its behalf.

Screening License. Genentech Exelixis agrees to grant and hereby grants (on behalf of itself and its Affiliates) Exelixis Genentech a worldwide, non-exclusive, royalty-bearing license, under the Yale Patents to the extent exclusively licensed to Genentech under Section 5.1 abovePatents, to screen Small Molecule Compounds against targets that are not Collaboration Targets but are within the Collaboration TargetsNotch signaling pathway. The foregoing license does not include the right to grant or authorize sublicenses; however, or to Genentech may have any screening activities of the foregoing performed on its behalf, where the benefit of that performance accrues primarily or exclusively to Genentech.